Oruka Therapeutics, Inc.

Direct answer

Oruka Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ORKA.

Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.

Can you invest in Oruka Therapeutics, Inc.?

Yes. Oruka Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ORKA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Oruka Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.